Compounding pharmacyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 15, 2026, FDA's public records list Abrams Royal Pharmacy with 5 drug recalls. The most recent is a drug recall dated Dec 19, 2013: MINERAL IV Injection, compounded by Abrams Royal Pharmacy, Inc., Dallas, TX.
| Dec 19, 2013 | MINERAL IV Injection, compounded by Abrams Royal Pharmacy, Inc., Dallas, TXClass I · Non-Sterility; analytical results found product to contain Sphingomonas paucimobilis | Drug recalls |
| Dec 19, 2013 | All Unexpired Sterile Drug Products, compounded by Abrams Royal Pharmacy Inc., Dallas, TXClass II · Lack of Assurance of Sterility | Drug recalls |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
